Ksenija Slavic

Ksenija Slavic

Auto-generated profile, based on publicly available information

Ksenija Slavic

Centre for Infection, Division of Cellular and Molecular Medicine, St. George's Hospital, University of London, SW17 0RE, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2016 in Nature Communications
Verified
Journal Article
Open access
KSKsenija Slavic
Ksenija Slavic
SKSanjeev Krishna
Sanjeev Krishna
ALAparajita Lahree
Aparajita Lahree
GBGuillaume Bouyer
Guillaume Bouyer
KHKirsten K. Hanson
Kirsten K. Hanson
MMMaria M. Mota
Maria M. Mota
Iron is an essential micronutrient but is also highly toxic. In yeast and plant cells, a key detoxifying mechanism involves iron sequestration into intracellular storage compartments, mediated by members of the vacuolar iron-transporter (VIT) family of proteins. Here we study the VIT homologue from the malaria parasites Plasmodium falciparum (PfVIT) and Plasmodium berghei (PbVIT). PfVIT-mediated iron transport in a yeast heterologous expression system is saturable (Km∼14.7 μM), and selective for Fe2+ over other divalent cations. PbVIT-deficient P. berghei lines (Pbvit−) show a reduction in parasite load in both liver and blood stages of infection in mice. Moreover, Pbvit− parasites have higher levels of labile iron in blood stages and are more sensitive to increased iron levels in liver stages, when compared with wild-type parasites. Our data are consistent with Plasmodium VITs playing a major role in iron detoxification and, thus, normal development of malaria parasites in their mammalian host.

15 June 2011 in Malaria Journal
Verified
Journal Article
Open access
PDF file
KSKsenija Slavic
Ksenija Slavic
SKSanjeev Krishna
Sanjeev Krishna
EDElvira T Derbyshire
Elvira T Derbyshire
HSHenry M. Staines
Henry M. Staines
Glucose is the primary source of energy and a key substrate for most cells. Inhibition of cellular glucose uptake (the first step in its utilization) has, therefore, received attention as a potential therapeutic strategy to treat various unrelated diseases including malaria and cancers. For malaria, blood forms of parasites rely almost entirely on glycolysis for energy production and, without energy stores, they are dependent on the constant uptake of glucose. Plasmodium falciparum is the most dangerous human malarial parasite and its hexose transporter has been identified as being the major glucose transporter. In this review, recent progress regarding the validation and development of the P. falciparum hexose transporter as a drug target is described, highlighting the importance of robust target validation through both chemical and genetic methods. Therapeutic targeting potential of hexose transporters of other protozoan pathogens is also reviewed and discussed.

8 March 2010 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
KSKsenija Slavic
Ksenija Slavic
USUrsula Straschil
Ursula Straschil
LRLuc Reininger
Luc Reininger
CDChristian Doerig
Christian Doerig
CMChristophe Morin
Christophe Morin
SKSanjeev Krishna
Sanjeev Krishna
Summary: A Plasmodium falciparum hexose transporter (PfHT) has previously been shown to be a facilitative glucose and fructose transporter. Its expression in Xenopus laevis oocytes and the use of a glucose analogue inhibitor permitted chemical validation of PfHT as a novel drug target. Following recent re‐annotations of the P. falciparum genome, other putative sugar transporters have been identified. To investigate further if PfHT is the key supplier of hexose to P. falciparum and to extend studies to different stages of Plasmodium spp., we functionally analysed the hexose transporters of both the human parasite P. falciparum and the rodent parasite Plasmodium berghei using gene targeting strategies. We show here the essential function of pfht for the erythrocytic parasite growth as it was not possible to knockout pfht unless the gene was complemented by an episomal construct. Also, we show that parasites are rescued from the toxic effect of a glucose analogue inhibitor when pfht is overexpressed in these transfectants. We found that the rodent malaria parasite orthologue, P. berghei hexose transporter (PbHT) gene, was similarly refractory to knockout attempts. However, using a single cross‐over transfection strategy, we generated transgenic P. berghei parasites expressing a PbHT–GFP fusion protein suggesting that locus is amenable for gene targeting. Analysis of pbht‐gfp transgenic parasites showed that PbHT is constitutively expressed through all the stages in the mosquito host in addition to asexual stages. These results provide genetic support for prioritizing PfHT as a target for novel antimalarials that can inhibit glucose uptake and kill parasites, as well as unveiling the expression of this hexose transporter in mosquito stages of the parasite, where it is also likely to be critical for survival.

1 July 2012 in Experimental Parasitology
Verified
Journal Article
Closed access
ODOlgica Djurkovic-Djakovic
Olgica Djurkovic-Djakovic
VDVitomir DJOKIC
Vitomir DJOKIC
MVMarija Vujanić
Marija Vujanić
TŽTijana Živković
Tijana Živković
BBBranko Bobić
Branko Bobić
VIVladimir Ivović
Vladimir Ivović

1 June 2011 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
KSKsenija Slavic
Ksenija Slavic
MDMichael J. Delves
Michael J. Delves
Miguel PrudêncioMiguel Prudêncio
Miguel Prudêncio
ATArthur M. Talman
Arthur M. Talman
USUrsula Straschil
Ursula Straschil
HSHenry M. Staines
Henry M. Staines
During blood infection, malarial parasites use d -glucose as their main energy source. The Plasmodium falciparum hexose transporter (PfHT), which mediates the uptake of d -glucose into parasites, is essential for survival of asexual blood-stage parasites. Recently, genetic studies in the rodent malaria model, Plasmodium berghei , found that the orthologous hexose transporter (PbHT) is expressed throughout the parasite's development within the mosquito vector, in addition to being essential during intraerythrocytic development. Here, using a d -glucose-derived specific inhibitor of plasmodial hexose transporters, compound 3361, we have investigated the importance of d -glucose uptake during liver and transmission stages of P. berghei . Initially, we confirmed the expression of PbHT during liver stage development, using a green fluorescent protein (GFP) tagging strategy. Compound 3361 inhibited liver-stage parasite development, with a 50% inhibitory concentration (IC 50 ) of 11 μM. This process was insensitive to the external d -glucose concentration. In addition, compound 3361 inhibited ookinete development and microgametogenesis, with IC 50 s in the region of 250 μM (the latter in a d -glucose-sensitive manner). Consistent with our findings for the effect of compound 3361 on vector parasite stages, 1 mM compound 3361 demonstrated transmission blocking activity. These data indicate that novel chemotherapeutic interventions that target PfHT may be active against liver and, to a lesser extent, transmission stages, in addition to blood stages.

28 February 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
DGDavid Guttery
David Guttery
JPJon K. Pittman
Jon K. Pittman
KFKarine Frénal
Karine Frénal
BPBenoit Poulin
Benoit Poulin
LMLeon R. McFarlane
Leon R. McFarlane
HSHenry M. Staines
Henry M. Staines
Ca2+ contributes to a myriad of important cellular processes in all organisms, including the apicomplexans, Plasmodium and Toxoplasma. Due to its varied and essential roles, free Ca2+ is tightly regulated by complex mechanisms. These mechanisms are therefore of interest as putative drug targets. One pathway in Ca2+ homeostatic control in apicomplexans uses a Ca2+/H+ exchanger (a member of the cation exchanger family, CAX). The P. falciparum CAX (PfCAX) has recently been characterised in asexual blood stage parasites. To determine the physiological importance of apicomplexan CAXs, tagging and knock-out strategies were undertaken in the genetically tractable T. gondii and P. berghei parasites. In addition, a yeast heterologous expression system was used to study the function of apicomplexan CAXs. Tagging of T. gondii and P. berghei CAXs (TgCAX and PbCAX) under control of their endogenous promoters could not demonstrate measureable expression of either CAX in tachyzoites and asexual blood stages, respectively. These results were consistent with the ability of parasites to tolerate knock-outs of the genes for TgCAX and PbCAX at these developmental stages. In contrast, PbCAX expression was detectable during sexual stages of development in female gametocytes/gametes, zygotes and ookinetes, where it was dispersed in membranous networks within the cytosol (with minimal mitochondrial localisation). Furthermore, genetically disrupted parasites failed to develop further from “round” form zygotes, suggesting that PbCAX is essential for ookinete development and differentiation. This impeded phenotype could be rescued by removal of extracellular Ca2+. Therefore, PbCAX provides a mechanism for free living parasites to multiply within the ionic microenvironment of the mosquito midgut. Ca2+ homeostasis mediated by PbCAX is critical and suggests plasmodial CAXs may be targeted in approaches designed to block parasite transmission. Calcium is vital to all living organisms. It is used within cells to regulate many essential processes and, because of this, its cellular concentration is tightly controlled. To change cellular calcium levels, cells use calcium transport proteins. These proteins can alter calcium concentration by moving calcium into or out of the cell or specialised calcium storage compartments within the cell. We know little about how single-celled apicomplexan parasites, including Plasmodium (the causal agent of malaria) and Toxoplasma (the causal agent of toxoplasmosis), regulate their calcium levels. Here, we have demonstrated that removing apicomplexan genes for a protein that exchanges calcium for protons across membranes (a Ca2+/H+ exchanger) and a member of the cation exchanger (CAX) family, does not affect the survival of parasites during those stages when they live within host cells. It is, however, lethal for the mouse malaria P. berghei when the parasite is free living within its mosquito vector. When we removed calcium from around the parasites at this stage they were able to develop normally, suggesting that the protein provides a mechanism for the parasite to tolerate environmental calcium. Learning how this calcium transport protein impacts on the development of apicomplexan parasites may lead to the development of novel anti-parasitic interventions.